These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4155633)

  • 1. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 6. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterisation of -receptor blocking agents.
    Saameli K
    Jpn J Pharmacol; 1972; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR; Vyas DS
    Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 13. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
    Tanenaka T; Tachikawa S
    Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
    Fekete MI; Elekes I; Kürti M; Borvendég J
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K; Köhler E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):79-86. PubMed ID: 4397216
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic effects of proadifen hydrochloride (SKF 525-A).
    Viana AP; Osswald W
    Arzneimittelforschung; 1970 Jun; 20(6):851-3. PubMed ID: 5468902
    [No Abstract]   [Full Text] [Related]  

  • 20. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.